Why the study?
SARS-CoV-1 and SARS-CoV-2 are not closely related phylogenetically yet both use human ACE2 for entry, an ability not universally shared across sarbecoviruses, leaving the evolutionary history of ACE2 usage unclear.
Population
Three sequences of a novel sarbecovirus from Rwanda and Uganda
Design
Phylogenetic analysis and in vitro functional studies
Authors
Loading...
Novel sarbecovirus sequences expand known diversity; leaves open ACE2 tropism evolution and zoonotic risk assessment.
Key points are not available for this paper at this time.
Wells et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: